Connection

Piero Portincasa to Italy

This is a "connection" page, showing publications Piero Portincasa has written about Italy.
Connection Strength

0.157
  1. Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver. Eur J Clin Invest. 2021 Jul; 51(7):e13597.
    View in: PubMed
    Score: 0.040
  2. Bismuth-based quadruple therapy following H. pylori eradication failures: a multicenter study in clinical practice. J Gastrointestin Liver Dis. 2017 Sep; 26(3):225-229.
    View in: PubMed
    Score: 0.031
  3. A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy. Eur J Clin Invest. 2017 Sep; 47(9):622-629.
    View in: PubMed
    Score: 0.030
  4. Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe. J Gastrointestin Liver Dis. 2017 Jun; 26(2):129-137.
    View in: PubMed
    Score: 0.030
  5. COVID-19, internists and resilience: the north-south Italy outbreak. Eur J Clin Invest. 2020 Jul; 50(7):e13299.
    View in: PubMed
    Score: 0.009
  6. Recurrence of COVID-19 after recovery: a case report from Italy. Infection. 2020 12; 48(6):965-967.
    View in: PubMed
    Score: 0.009
  7. Sequential therapy for first-line Helicobacter pylori eradication: 10- or 14-day regimen? J Gastrointestin Liver Dis. 2019 Mar; 28(1):11-14.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.